Method of COVID-19 vaccine delivery in cells may be linked to cause of rare clot reaction, researchers say

A team of German researchers has suggested a mechanism behind rare but serious clotting events in recipients of COVID-19 vaccines developed by AstraZeneca and Johnson & Johnson.